Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage
Geographical Focus
Belgium
Industries Focus
- Software
- HealthTech
- Biotech
- DeepTech
Investment Size:
100,000 to 1,500,000 USD
Investor Details Founded: 2016
Qbic II is a Belgian venture capital fund that focuses on transforming technological breakthroughs into sustainable businesses. It primarily invests in spin-offs and start-ups that have a strong connection to Qbic's partner universities and research institutions. The fund typically participates in the first external investment round of a company and continues to support these companies throughout their growth.
The fund's investment strategy is sector-agnostic, supporting a diverse range of industries, including Biotech, HealthTech, DeepTech, and Software. Qbic II has a fund size of €58.9 million and has invested in 19 ventures. The investment period for Qbic II ended in 2022, and the fund is now focusing on follow-on investments and exits.
Qbic II is managed by an independent team of seasoned investment and business professionals. The fund is one of the largest inter-university spin-off funds in Europe, with close to €100 million under management across its different funds. It collaborates with a network of Belgian universities, research institutes, and hospitals, providing early and privileged access to promising research projects at these partner institutions.
Requirements
- Strong connection to Qbic's partner universities and research institutions
- Innovative business models with high growth potential
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Spica Therapeutics
- Innocens
- Obulytix
- MRM Health
- Aloxy
- Blue Foot
- Trince
- AmphiStar
- Flindr
Claim this Investor
Are you an official representative of Qbic II?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim